Xilio Therapeutics

Xilio Therapeutics

MA - Waltham
Biotechnology

Focus: Cancer Immunotherapies

Xilio Therapeutics is a life sciences company focused on Cancer Immunotherapies.

Oncology
Open Jobs
0

Pipeline & Clinical Trials

Phase 1/2
Clinical Trials (1)
NCT05052268XTX202 in Patients With Advanced Solid Tumors
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT04896697Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors
Phase 1/2
Phase 1/2
Clinical Trials (1)
NCT05684965XTX301 in Patients With Advanced Solid Tumors
Phase 1/2

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts
Portfolio: 3 clinical trials

Hiring Trend

Stable
0
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles